ORAMED PHARMACEUTICALS INC (ORMP) Forecast, Price Target & Analyst Ratings

NASDAQ:ORMP • US68403P2039

Current stock price

3.31 USD
-0.01 (-0.3%)
At close:
3.24 USD
-0.07 (-2.11%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ORAMED PHARMACEUTICALS INC (ORMP).

Forecast Snapshot

Consensus Price Target

Price Target
$6.38
+ 92.60% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 12, 2026
Period
Q4 / 2025
EPS Estimate
$0.00
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.38
Upside
+ 92.60%
From current price of $3.31 to mean target of $6.38, Based on 6 analyst forecasts
Low
$6.31
Median
$6.38
High
$6.56

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for ORMP. The average price target is 6.38 USD. This implies a price increase of 92.6% is expected in the next year compared to the current price of 3.31.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ORMP Current Analyst RatingORMP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

ORMP Historical Analyst RatingsORMP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
ORMP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ORMP.
In the previous month the buy percentage consensus was at a similar level.
ORMP was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-09-09HC Wainwright & Co.Reiterate Neutral
2024-05-20HC Wainwright & Co.Reiterate Neutral
2023-05-17Canaccord GenuityMaintains Hold -> Hold
2023-01-17HC Wainwright & Co.Downgrade Buy -> Neutral
2023-01-12Canaccord GenuityDowngrade Buy -> Hold
2022-05-16Aegis CapitalMaintains Buy
2022-02-18Cantor FitzgeraldInitiate Overweight
2021-11-30HC Wainwright & Co.Maintains Buy
2021-11-29HC Wainwright & Co.Maintains Buy
2021-11-02Aegis CapitalMaintains Buy
2021-07-29Canaccord GenuityMaintains Buy
2021-06-08Aegis CapitalMaintains Buy
2021-04-20Canaccord GenuityInitiate Buy
2021-02-09National Securities CorporationInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 12, 2026
Period
Q4 / 2025
EPS Estimate
$0.00
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

ORMP is expected to report earnings on 8/12/2026. The consensus EPS estimate for the next earnings is 0 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ORMP revenue by date.ORMP revenue by date.
2.7M
-0.37%		2.7M1.34M
-50.37%
-100.00%		2.04M
-100.00%
EBITDA
YoY % growth
ORMP ebitda by date.ORMP ebitda by date.
-24.14M
-105.45%		-40.54M
-67.94%		-15.573M
61.59%		N/A
19.17%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ORMP ebit by date.ORMP ebit by date.
-24.22M
-105.95%		-40.6M
-67.63%		-15.769M
61.16%		-14.278M
18.95%		-12.648M
1.04%		-52.53M
-315.32%		-53.652M
-2.14%		-54.876M
-2.28%		-56.1M
-2.23%		-57.324M
-2.18%
Operating Margin
ORMP operating margin by date.ORMP operating margin by date.
-897.04%-1,503.70%-1,176.79%N/A-620.00%N/AN/AN/AN/AN/A
EPS
YoY % growth
ORMP eps by date.ORMP eps by date.
-0.78
-33.89%		-0.94
-21.05%		0.14
114.89%		-0.04
-228.57%		1.31
825.33%		-1.29
-198.44%		-0.84
34.92%		-0.74
10.98%		-0.67
9.59%		-0.62
7.58%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		0.00
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-3.06M
14.88%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ORMP Yearly Revenue VS EstimatesORMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2025 500K 1M 1.5M 2M 2.5M
ORMP Yearly EPS VS EstimatesORMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-66.87%
EPS Next 5 Year
-30.19%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ORAMED PHARMACEUTICALS INC / ORMP Forecast FAQ

Can you provide the average price target for ORAMED PHARMACEUTICALS INC stock?

6 analysts have analysed ORMP and the average price target is 6.38 USD. This implies a price increase of 92.6% is expected in the next year compared to the current price of 3.31.

What is the next earnings date for ORMP stock?

ORAMED PHARMACEUTICALS INC (ORMP) will report earnings on 2026-08-12.

What are the consensus estimates for ORAMED PHARMACEUTICALS INC (ORMP) next earnings?

The consensus EPS estimate for the next earnings of ORAMED PHARMACEUTICALS INC (ORMP) is 0 USD and the consensus revenue estimate is 0 USD.